S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
ASX:EYE

Nova Eye Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive EYE News and Ratings via Email

Sign-up to receive the latest news and ratings for Nova Eye Medical and its competitors with MarketBeat's FREE daily newsletter.


About Nova Eye Medical

Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Nova Eye Medical (ASX:EYE) Frequently Asked Questions

What stocks does MarketBeat like better than Nova Eye Medical?

Wall Street analysts have given Nova Eye Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nova Eye Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Nova Eye Medical's key executives?

Nova Eye Medical's management team includes the following people:
  • Mr. Victor Previn B.E., B.Eng, Founder & Exec. Chairman (Age 63, Pay $247.38k)
  • Ms. Kimberley Menzies, Group Financial Controller & Global Fin. Mang.
  • Mr. Keith Byrne, VP of Global Operations
  • Dr. Thomas Duthy M.B.A., Ph.D., Head of Investor Relations & Corp. Devel.
  • Ms. Kate Hunt, Head of Marketing
  • Mr. Thomas H. Spurling, Consultant & Director (Age 59)
  • Dr. David Lubeck M.D., Chief Medical Officer
  • Mr. Bill Swaim, Pres of Laserex IS Ellex (USA)
  • Mr. Joaquin V. Wolff, Pres of Ellex iTrack (Age 63)
  • Mr. Simon Jeremy Newton Gray C.A., BEc, CA, Company Sec. (Age 62)

What is Nova Eye Medical's stock symbol?

Nova Eye Medical trades on the ASX under the ticker symbol "EYE."

How much money does Nova Eye Medical make?

Nova Eye Medical has a market capitalization of $0.00 and generates $13.60 million in revenue each year.

How many employees does Nova Eye Medical have?

Nova Eye Medical employs 12,792 workers across the globe.

What is Nova Eye Medical's official website?

The official website for Nova Eye Medical is www.ellex.com.

Where are Nova Eye Medical's headquarters?

Nova Eye Medical is headquartered at 2435 Commerce Ave Bldg 2200, Duluth, Georgia 30096-4980.

How can I contact Nova Eye Medical?

Nova Eye Medical's mailing address is 2435 Commerce Ave Bldg 2200, Duluth, Georgia 30096-4980. The company can be reached via phone at 61 8 7074 8200.


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.